Table 1 from Structurally Oriented Classification of <i>FOXA1</i> Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes
Purpose: To analyze the variability, associated actors, and the design of nomograms for individualized testosterone recovery after cessation of androgen deprivation therapy (ADT). Materials and Method
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa). MethodsPatients diagnosed with cN1M0 PCa were extracted from the surveillance, epidemiology, and end
Background Docetaxel, a lipophilic drug, is indicated for castration-resistant metastatic prostate cancer. Most men with such disease would have had androgen-deprivation therapy, which decreases muscl
Objective: To assess the extent of early mortality and its temporal course after prostatectomy and radiotherapy in the general population. Methods: Data from the Surveillance, Epidemiology, and End Re
Incidensen af prostatakræft i Danmark er den næststørste efter lungecancer. I 2003 blev der diagnosticeret 2400 nye tilfælde af prostatakræft. Ofte kan mænd, diagnosticeret med prostatakræft, forvente
